Lightwave Logic's valuation is too high, with commercialization still a long way off and current revenue offering little guidance. Its smartest move is integrating with existing silicon photonics and InP supply chains rather than replacing them, and its 2026 foundry partnership has won market credibility, reflected in a tenfold rise over the past year. It is not worth chasing; dips are the better entry. x.com 

Lightwave Logic is valued at $2B with just 34 employees and zero revenue after 34 years in business. x.com 

Lightwave Logic is a genuinely interesting lottery ticket that wins big if electro-optic polymers become the standard. Its Tower Semiconductor deal puts its modulators, targeting 400G per lane, into a widely used foundry design kit open to any Tower customer, including Nvidia. Its CEO was at Oclaro when Lumentum bought it and advised on IPG's coherent division, also sold to Lumentum, a playbook it could repeat. A 70% run could be a potential top signal, but it does not look topped yet. x.com 

Lightwave Logic's multibillion-dollar market cap looks hard to justify because it has technology and products but almost no sales. Its Perkinamine polymer modulators use less power, are smaller and twice as efficient as lithium niobate or silicon, and fit existing silicon photonics lines. But 2025 revenue was only $237K against a $20.3M net loss and -$15.1M free cash flow, with losses expected through 2027. The market is betting on adoption as CPO expands, so expect 20% swings on news. x.com 

Lightwave Logic is not a buy yet because commercialization is too far off. Its technology is brilliant and clearly disruptive, and the pipeline is moving, with four customers including Marvell/Polarion in the prototype-to-product stage and one or two more expected by Q3 2026. But high-volume production is not targeted until the second half of 2027. It is a classic high-beta story that swung from $5 to $18 and back to $9, and it could become an interesting investment in 6 to 18 months. x.com 

Lightwave Logic could be one of the biggest winners if it executes, and the odds improve daily. It licenses its electro-optic polymer platform like Arm, with high margins and low capex; cash lasts to end-2027, matching its target to move Stage 3 customers into production. Polymer devices passed 2,000 hours of damp-heat testing, the telecom-grade bar. If 2-3 customers ramp, royalties could reach $30-50M, worth up to about $1.25B at 25x. Much is priced in, so adding on pullbacks is best. x.com 

Lightwave Logic is a short because all of its income depends on one contract that may not be renewed. Its polymers are used by Polariton, which Marvell bought for its plasmonics, but that contract expires next year with no sign of renewal; Marvell quickly canceled the POET contract it inherited via Celestial AI. 2025 research favors lithium niobate over organic materials for stability, which matters most for co-packaged optics reliability, and Marvell calls its design material-agnostic. x.com  … Show more

Lightwave Logic's $1.8B valuation makes no sense for a company without revenue, making it the Rigetti of photonics. Foxconn's optical arm Shunsin, which handles live packaging, assembly and testing for NVIDIA's co-packaged optics, is valued at only $1.4B, and Sivers, a laser source for Jabil and Marvell, was valued at a third of Lightwave earlier this week. Institutions appear to have piled into the wrong name on the strength of a development test agreement with Tower Semiconductor. x.com  x.com 

Rising 1.6T switching demand favors optical suppliers, though their execution risks vary. Bank of America says the market could grow ~101% annually through 2030. Marvell's leading DSPs and Lumentum's supply-short 200G EML lasers are lowest risk; Applied Optoelectronics' capacity expansion and Fabrinet's customer concentration make them medium risk. Aeluma remains pre-commercial, while Lightwave Logic's polymer modulators are a high-risk moonshot despite its TSM partnership. x.com 

Lightwave Logic is not a buy here because its run has carried it into long-term resistance on the monthly chart while the company still doesn't appear to make any money. x.com